Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life
Bruno Sposato, Gianna Camiciottoli, Elena Bacci, et al.
Pulmonary Pharmacology & Therapeutics (2020) Vol. 61, pp. 101899-101899
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

EAACI Biologicals Guidelines—Recommendations for severe asthma
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2020) Vol. 76, Iss. 1, pp. 14-44
Open Access | Times Cited: 217
Biologics and airway remodeling in severe asthma
Gilda Varricchi, Sebastian Ferri, J. Pepys, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3538-3552
Open Access | Times Cited: 145
Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline
Sumita Khatri, Jonathan M. Iaccarino, Amisha V. Barochia, et al.
American Journal of Respiratory and Critical Care Medicine (2021) Vol. 204, Iss. 10, pp. e97-e109
Open Access | Times Cited: 105
Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis
David Charles, Jemma Shanley, Sasha‐Nicole Temple, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 5, pp. 616-627
Open Access | Times Cited: 79
Molecular Targets for Biological Therapies of Severe Asthma
Corrado Pelaia, Claudia Crimi, Alessandro Vatrella, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 101
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand
John Blakey, Li Ping Chung, Vanessa M. McDonald, et al.
Respirology (2021) Vol. 26, Iss. 12, pp. 1112-1130
Open Access | Times Cited: 63
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2455-2455
Open Access | Times Cited: 34
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3371-3371
Open Access | Times Cited: 27
Small airways in asthma: From inflammation and pathophysiology to treatment response
Anastasia Siora, Angelos Vontetsianos, Nikolaos Chynkiamis, et al.
Respiratory Medicine (2024) Vol. 222, pp. 107532-107532
Closed Access | Times Cited: 9
Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype
Corrado Pelaia, Claudia Crimi, Girolamo Pelaia, et al.
Clinical & Experimental Allergy (2020) Vol. 50, Iss. 7, pp. 780-788
Closed Access | Times Cited: 68
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
Corrado Pelaia, Claudia Crimi, Alida Benfante, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 163-173
Open Access | Times Cited: 52
Small airway dysfunction and poor asthma control: a dangerous liaison
Marcello Cottini, Anita Licini, Carlo Lombardi, et al.
Clinical and Molecular Allergy (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 42
Critical evaluation of asthma biomarkers in clinical practice
Giuseppe Guida, Diego Bagnasco, Vitina Carriero, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 35
Impact of Biologic Therapy on the Small Airways Asthma Phenotype
Rory Chan, Brian J. Lipworth
Lung (2022) Vol. 200, Iss. 6, pp. 691-696
Open Access | Times Cited: 25
Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review
Tommaso Pianigiani, Lorenzo Alderighi, Martina Meocci, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 400-400
Open Access | Times Cited: 13
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysis
Donald R. DiBona, Giovanni Paoletti, Palma Carlucci, et al.
Journal of Asthma (2025), pp. 1-11
Closed Access
Small airways dysfunction in severe asthma: Current treatment approaches and future directions
Nishan Deng, Yunyan Xianyu, Yaqing Xu, et al.
Journal of the Formosan Medical Association (2025)
Open Access
Effects of biologic therapy on novel indices of lung inhomogeneity in patients with severe type-2 high asthma
Asma Alamoudi, Lorenzo Petralia, Nicholas M. J. Smith, et al.
BMJ Open Respiratory Research (2025) Vol. 12, Iss. 1, pp. e002721-e002721
Open Access
Physiological Small Airways Dysfunction and the Bronchodilator Response in Adults With Asthma and Its Risk Factors: A Retrospective Analysis
Mohammed A. Almeshari, Nowaf Y. Alobaidi, James Stockley, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 377-389
Open Access
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma
Corrado Pelaia, Maria Teresa Busceti, Claudia Crimi, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110444-110444
Open Access | Times Cited: 34
Small-airway dysfunction in paediatric asthma
Marcello Cottini, Carlo Lombardi, Alvise Berti, et al.
Current Opinion in Allergy and Clinical Immunology (2021) Vol. 21, Iss. 2, pp. 128-134
Closed Access | Times Cited: 31
Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
Elliot Israel, Giorgio Walter Canonica, Guy Brusselle, et al.
Journal of Asthma (2021) Vol. 59, Iss. 11, pp. 2201-2217
Open Access | Times Cited: 29
Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study
Mustafa Abdo, Henrik Watz, Vera Veith, et al.
Respiratory Research (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 31
Small Airways: The “Silent Zone” of 2021 GINA Report?
Marcello Cottini, Carlo Lombardi, Giovanni Passalacqua, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 17
Real-Life Effectiveness of Mepolizumab on Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity in Patients with Severe Eosinophilic Asthma
Angelantonio Maglio, Carolina Vitale, Simona Pellegrino, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1550-1550
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top